NPPA fixes ceiling prices for 84 drug formulations; focus on Empagliflozin-based Diabetes therapies Ruchika Sharma8 May 2025 2:14 PM ISTNew Delhi: In a fresh directive aimed at curbing treatment costs and improving access to essential medicines, the National Pharmaceutical Pricing...
CDSCO panel rejects USV Pharmaceuticals' proposal of CT study waiver for fenofibrate tablets in diabetic retinopathy Dr. Divya Colin28 April 2025 6:00 PM ISTNew Delhi: Noting that the presented safety data was not adequate in terms of long-term safety, the Subject Expert Committee (SEC) functional under...
USV Launches Empagliflozin Range Under Xenia Brand Deeksha Bhandari2 April 2025 12:23 PM ISTUSV Pvt. Ltd., a leader in diabetes care, has announced the launch of its Xenia brand range in India, following the patent expiry of Empagliflozin. ...
USV Launches Xenia Brand Range Following Empagliflozin Patent Expiry Deeksha Bhandari21 March 2025 6:00 PM ISTNew Delhi: Strengthening its leadership in diabetes care, USV Pvt. Ltd. has announced the launch of its Xenia brand range, following...
GSK's Augmentin Leads Indian Pharma Market in October with Rs 843 Crore Sales: Pharmatrac Report Farhat Nasim22 Nov 2024 5:40 PM ISTNew Delhi: As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the test of time...
Indian Pharma Market Grows 5.3% in September, Sun Pharma, Cipla take the lead: Pharmarack report Farhat Nasim14 Oct 2024 5:45 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) witnessed a growth of 5.3% in September 2024, primarily driven by the robust performance of key...
USV kickstarts dedicated new plant in Baddi, HP Ruchika Sharma14 March 2024 4:48 PM IST"This modern facility is of strategic importance to serve Indians to keep their heart healthy by offering a lifesaving quality brand at an affordable...
Indian Pharma Market registers 8 percent surge to Rs 17,937 Crore in January 2024: IQVIA Farhat Nasim19 Feb 2024 7:19 PM ISTNew Delhi: In an impressive kickoff to 2024, the Indian pharmaceutical market surged by 8%, reaching a substantial Rs 17,937 crore in January, as per...
USV Launches INSUQUICK, First Biosimilar Insulin Aspart in India MD Brand Connect1 Nov 2023 5:39 PM ISTUSV Pvt. Ltd, leaders in oral anti-diabetes segment, has announced the launch of 1st biosimilar Insulin Aspart in India, INSUQUICK, for the...
USV Launches Liralin Range for Diverse Group of Type 2 Diabetes Patients MD Brand Connect4 Sept 2023 1:55 PM ISTUSV Pvt. Ltd, a leading drug manufacturer in the diabetes & cardiology segment, has announced the launch of the Liralin Range for the treatment...
USV Launches Roseday CV at a Patient-Centric Price for Indian Cardiac Patients MD Brand Connect24 Aug 2023 12:04 PM ISTThe recent AHA/ACC 2023 Guidelines for Chronic Coronary Disease recommend considering medication costs to prevent cost-related non-adherence....
USV Launches Jalra Trio for Management of Type 2 Diabetes in India MD Brand Connect11 Aug 2023 12:22 PM ISTUSV Pvt. Ltd, a leading drug manufacturer in the anti-diabetic segment, has announced the launch of the brand Jalra Trio for the treatment of...
